As part of LumiraDx's Fast Lab Solutions, the test enables laboratories to increase throughput of their existing open channel PCR systems to more than 250 tests per hour This innovative molecular test ...
SAN ANTONIO, Texas--(BUSINESS WIRE)--NucleoBio, Corp., a leading biotechnology innovator in precision oncology diagnostics, and PreCheck Health Services, a high-complexity CLIA-certified and ...
LONDON, Nov. 14, 2022 /PRNewswire/ -- LumiraDx Limited (Nasdaq: LMDX), a next-generation point of care diagnostics company, today announced the continued commercial expansion of its HbA1c test, for ...
In the rapidly evolving field of drug discovery, the adoption of in vitro models offers a promising alternative to traditional animal testing. These models not only provide a more ethical approach by ...
HOUSTON, Feb. 26, 2025 /PRNewswire/ -- Avance Biosciences, a leading provider of high-quality analytical and bioanalytical services for the pharmaceutical industry, is pleased to announce that it has ...
Cepheid announced the U.S. Food & Drug Administration (FDA) has categorized Cepheid's Xpert® CT/NG test as 'Moderate Complexity' under the Clinical Laboratory Improvement Amendments (CLIA). Xpert ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback